| » | Product is facing Gx competition after coming off-patent. |
| » | IDrug conducted a benchmark study between originator and Gx competitors, focusing on purity, API concentration, stability, as well as physiological activity of the drug. |
Result
| » | IDrug´s analysis concluded that several of the competing Gx copies had an inferior quality compared to the originator product. |